In vitro cytotoxicity of polyphosphoester as a novel injectable alveolar replacement material

Abstract

The aim of this study was to investigate the in vitro cytotoxicity of polyphosphoester polymer used as a novel injectable alveolar bone substitutes for controlled delivery of tetracycline. Cell culture medium was exposed to the polymer (0.01–10 mg/mL) for 24 h. The L-929 mouse fibroblasts were then exposed to the treated cell culture medium for 24 h. Finally, cell viability and growth were assessed by using MTT assay and Alamar Blue assay. No significant cytotoxicity of the polyphosphoester against L-929 mouse fibroblasts was observed at a concentration up to 10 mg/mL (P>0.05). The two evaluation methods showed no significant differences (P>0.05). This study suggests that polyphosphoester does not demonstrate any significant toxic effects to cells in vitro and has the potential to be used both as a medical device and as scaffolds in tissue engineering applications.

Keywords

polyphosphoester / cytotoxicity / MTT assay / Alamar Blue test

References

[1] MinabeM.. A critical review of the biologic rationale for guided tissue regeneration. J Periodontol, 1991, 62(3): 171-179

[2] BuckB. E., MalininT. I., BrownM. D.. Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop, 1989, 240: 129-136

[3] HatefiA., AmsdenB.. Biodegradable injectable in situ forming drug delivery systems. J Controlled Release, 2002, 80(1): 9-28

[4] PayneR. G., YaszemskiM. J., YaskoA. W., et al.. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles. Biomaterials, 2002, 23(22): 4359-4371

[5] QiuJ. J., LiuC. M., HuF., et al.. Synthesis of unsaturated polyphosphoester as a potential injectable tissue engineering scaffold material.. J Applied Polymer Sci, 2006, 102(4): 3095-3101

[6] Xiao J Z, Mao J, Zhang Z X et al. In vitro degradation of a UPPE/β-TCP composite orthopedic scaffold. Tissue Eng, In press

[7] MosmannT.. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983, 65(1–2): 55-63

[8] StevensM. G., OlsenS. C.. Comparative analysis of using MTT and XTT in colorimetric assays for quantitating bovine neutrophil bactericidal activity. J Immunol Methods, 1993, 157(1–2): 225-231

[9] AhmedS. A., GogalR. M.Jr, WalshJ. E.. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. J Immunol Methods, 1994, 170(2): 211-222

[10] Al-NasiryS., GeusensN., HanssensM., et al.. The use of AlamarBlue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod, 2007, 22(5): 1304-1309

[11] HaraS., MukaeH., SakamotoN., et al.. Plectasin has antibacterial activity and no affect on cell viability or IL-8 production. Biochem Biophys Res Commun, 2008, 374(4): 709-713

[12] Anon (2000). Biological Reactivity Tests In Vitro, United States Pharmacopeia, 24th Revision, pp. 1813–1831. Rockville, MD: United States Pharmacopeial Convention, Inc.

[13] MistryA. S., MikosA. G., JansenJ. A.. Degradation and biocompatibility of a poly(propylene fumarate)-based/alumoxane nanocomposite for bone tissue engineering. J Biomed Mater Res A, 2007, 83(4): 940-953

[14] SuggsL. J., ShiveM. S., GarciaC. A., et al.. In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mater Res, 1999, 46(1): 22-32

[15] BernasT., DobruckiJ.. Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry, 2002, 47(4): 236-242

[16] HamidR., RotshteynY., RabadiL., et al.. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro, 2004, 18(5): 703-710

[17] PizzoferratoA., CiapettiG., SteaS.. Cell culture methods for testing biocompatibility. Clin Mater, 1994, 15(3): 173-190

[18] DahiyatB. I., RichardsM., LeongK. W.. Controlled release from poly(phosphoester) matrices. J Controlled Release, 1995, 33(1): 13-21

[19] RichardsM., DahiyatB. I., ArmD. M., et al.. Evaluation of polyphosphates and polyphosphonates as degradable biomaterials. J Biomed Mater Res, 1991, 25(4): 1151-1167

[20] ISO 10993-5: Biological evaluation of medical devices. Part5—Tests for cytotoxicity: in vitro methods. Geneva, Switzerland: International Organization for Standardization